A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year

The Tema Cardiovascular and Metabolic ETF holds positions in around 20 companies, including Novo Nordisk and Eli Lilly.

https://markets.businessinsider.com/news/etf/ozempic-weight-loss-etf-eli-lilly-novo-nordisk-stock-market-2023-11